Abstract CT013: S1616: Ipilimumab plus nivolumab versus ipilimumab alone in patients with metastatic or unresectable melanoma that did not respond to anti-PD-1 therapy
Year: 2022
Type: conference-abstract
Source: Cancer Research
Institutions: Germantown Historical Society, The Ohio State University Wexner Medical Center, Moffitt Cancer Center, UNC Lineberger Comprehensive Cancer Center, University of Oklahoma Health Sciences Center, University of Rochester, Kaiser Permanente, Kaiser Permanente Vallejo Medical Center, University of California, Los Angeles, UCLA Jonsson Comprehensive Cancer Center, Fred Hutch Cancer Center, University of Utah, Huntsman Cancer Institute
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W4282980622